Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stavros Sfoungaristos

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Expert Opinion on Pharmacotherapy|June 1, 2012
A systematic review of the role of adjuvant and neoadjuvant pharmacotherapy in patients undergoing radical prostatectomyStavros Sfoungaristos, Petros Perimenis
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 15, 2013
Parameters predicting postoperative unilateral disease in patients with unilateral prostate cancer in diagnostic biopsy: a rationale for selecting hemiablative focal therapy candidatesStavros Sfoungaristos, Petros Perimenis
ISRN Urology|June 14, 2013
Evaluating PSA Density as a Predictor of Biochemical Failure after Radical Prostatectomy: Results of a Prospective Study after a Median Follow-Up of 36 MonthsStavros Sfoungaristos, Petros Perimenis
International Urology and Nephrology|March 26, 2011
PSA density versus risk stratification for lymphadenectomy-making decision in patients with prostate cancer undergoing radical prostatectomyStavros Sfoungaristos, Petros Perimenis
Asian Pacific Journal of Cancer Prevention : APJCP|December 1, 2011
Implications of PSA kinetics for an adverse pathology after radical prostatectomyStavros Sfoungaristos, Petros Perimenis
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 8, 2012
PSA density is superior than PSA and Gleason score for adverse pathologic features prediction in patients with clinically localized prostate cancerStavros Sfoungaristos, Petros Perimenis
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 15, 2013
Clinical and pathological variables that predict changes in tumour grade after radical prostatectomy in patients with prostate cancerStavros Sfoungaristos, Petros Perimenis
Urology Journal|October 1, 2013
Bilateral cancer in prostate biopsy associates with the presence of extracapsular disease and positive surgical margins in low risk patients: a consideration for bilateral nerve sparing radical prostatectomy decisionStavros Sfoungaristos, Petros Perimenis
Expert Opinion on Pharmacotherapy|February 11, 2011
Present and future therapeutic options for locally advanced and metastatic renal cell carcinomaStavros Sfoungaristos, Konstantinos Giannitsas, Petros Perimenis
Biomed Research International|October 29, 2013
Early continence recovery after preservation of maximal urethral length until the level of verumontanum during radical prostatectomy: primary oncological and functional outcomes after 1 year of follow-upStavros Sfoungaristos, Stavros Kontogiannis, Petros Perimenis
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Expert Opinion on Pharmacotherapy|June 1, 2012
A systematic review of the role of adjuvant and neoadjuvant pharmacotherapy in patients undergoing radical prostatectomyStavros Sfoungaristos, Petros Perimenis
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 15, 2013
Parameters predicting postoperative unilateral disease in patients with unilateral prostate cancer in diagnostic biopsy: a rationale for selecting hemiablative focal therapy candidatesStavros Sfoungaristos, Petros Perimenis
ISRN Urology|June 14, 2013
Evaluating PSA Density as a Predictor of Biochemical Failure after Radical Prostatectomy: Results of a Prospective Study after a Median Follow-Up of 36 MonthsStavros Sfoungaristos, Petros Perimenis
International Urology and Nephrology|March 26, 2011
PSA density versus risk stratification for lymphadenectomy-making decision in patients with prostate cancer undergoing radical prostatectomyStavros Sfoungaristos, Petros Perimenis
Asian Pacific Journal of Cancer Prevention : APJCP|December 1, 2011
Implications of PSA kinetics for an adverse pathology after radical prostatectomyStavros Sfoungaristos, Petros Perimenis
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 8, 2012
PSA density is superior than PSA and Gleason score for adverse pathologic features prediction in patients with clinically localized prostate cancerStavros Sfoungaristos, Petros Perimenis
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 15, 2013
Clinical and pathological variables that predict changes in tumour grade after radical prostatectomy in patients with prostate cancerStavros Sfoungaristos, Petros Perimenis
Urology Journal|October 1, 2013
Bilateral cancer in prostate biopsy associates with the presence of extracapsular disease and positive surgical margins in low risk patients: a consideration for bilateral nerve sparing radical prostatectomy decisionStavros Sfoungaristos, Petros Perimenis
Expert Opinion on Pharmacotherapy|February 11, 2011
Present and future therapeutic options for locally advanced and metastatic renal cell carcinomaStavros Sfoungaristos, Konstantinos Giannitsas, Petros Perimenis
Biomed Research International|October 29, 2013
Early continence recovery after preservation of maximal urethral length until the level of verumontanum during radical prostatectomy: primary oncological and functional outcomes after 1 year of follow-upStavros Sfoungaristos, Stavros Kontogiannis, Petros Perimenis
Pageof 5